{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:52:26Z","timestamp":1795024346364,"version":"4.10.2"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate the risk of recurrence and reintervention after uterine-sparing treatment options for symptomatic adenomyosis, including adenomyomectomy, uterine artery embolization (UAE), and image-guided thermal ablation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>We searched electronic databases such as Web of Science, MEDLINE, Cochrane Library, EMBASE, ClinicalTrials.gov, and Google Scholar from January 2000 to January 2022. The search was conducted using the following search terms: \u201cadenomyosis,\u201d \u201crecurrence,\u201d \u201creintervention,\u201d \u201crelapse,\u201d and \u201crecur.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>\n                      All studies that described the risk of recurrence or reintervention after uterine-sparing interventions for symptomatic adenomyosis were reviewed and screened according to the eligibility criteria.\n                      <jats:italic toggle=\"yes\">Recurrence<\/jats:italic>\n                      was defined as the reappearance of symptoms (painful menses or heavy menstrual bleeding) after significant or complete remission, or the reappearance of adenomyotic lesions confirmed by ultrasonography or magnetic resonance imaging.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>The outcome measures were presented as the frequency with percentage and pooled with 95% CI. A total of 42 studies (single-arm retrospective and prospective studies) that represented 5,877 patients were included. The recurrence rates after adenomyomectomy, UAE, and image-guided thermal ablation were 12.6% (95% CI 8.9\u201316.4%), 29.5% (95% CI 17.4\u201341.5%), and 10.0% (95% CI 5.6\u201314.4%), respectively. The reintervention rates were 2.6% (95% CI 0.9\u20134.3%), 12.8% (95% CI 7.2\u201318.4%), and 8.2% (95% CI 4.6\u201311.9%) after adenomyomectomy, UAE, and image-guided thermal ablation, respectively. Subgroup analysis and sensitivity analysis were performed, and the heterogeneity was reduced in several analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Uterine-sparing techniques were successful in treating adenomyosis with low reintervention rates. Uterine artery embolization had higher recurrence and reintervention rates than other techniques; however, patients treated with UAE had larger uteri and larger adenomyosis, indicating that selection bias may influence these results. More randomized controlled trials with a larger population are needed in the future.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SYSTEMATIC REVIEW REGISTRATION:<\/jats:title>\n                    <jats:p>PROSPERO, CRD42021261289.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005080","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T10:01:38Z","timestamp":1678442498000},"page":"711-723","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Risk of Recurrence and Reintervention After Uterine-Sparing Interventions for Symptomatic Adenomyosis"],"prefix":"10.1097","volume":"141","author":[{"given":"Lu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"R1-20261107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bpobgyn.2016.09.006","article-title":"Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management","volume":"40","author":"Abbott","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R2-20261107","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/humupd\/dms006","article-title":"Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes","volume":"18","author":"Maheshwari","year":"2012","journal-title":"Hum Reprod Update"},{"key":"R3-20261107","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1093\/humrep\/des332","article-title":"How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic","volume":"27","author":"Naftalin","year":"2012","journal-title":"Hum Reprod"},{"key":"R4-20261107","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.2020.26436","article-title":"Diagnosis, evaluation, and treatment of adenomyosis","volume":"326","author":"Kho","year":"2021","journal-title":"JAMA"},{"key":"R5-20261107","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bpobgyn.2006.01.012","article-title":"Medical and surgical management of adenomyosis","volume":"20","author":"Farquhar","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R6-20261107","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0040-1718921","article-title":"Current and future surgical and interventional management options for adenomyosis","volume":"38","author":"Chen","year":"2020","journal-title":"Semin Reprod Med"},{"key":"R7-20261107","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.fertnstert.2008.07.1744","article-title":"Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma","volume":"92","author":"Wang","year":"2009","journal-title":"Fertil Steril"},{"key":"R8-20261107","first-page":"1322","article-title":"Characteristics and efficacy of modified adenomyomectomy in the treatment of uterine adenomyoma","volume":"124","author":"Sun","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"R9-20261107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tjog.2012.12.002","article-title":"Long-term follow-up of severely symptomatic women with adenomyoma treated with combination therapy","volume":"52","author":"Liu","year":"2013","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R10-20261107","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5468\/ogs.2014.57.2.128","article-title":"Laparoscopic assisted adenomyomectomy using double flap method","volume":"57","author":"Kim","year":"2014","journal-title":"Obstet Gynecol Sci"},{"key":"R11-20261107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejogrb.2013.11.014","article-title":"Long-term efficacy and quality of life associated with laparoscopic bilateral uterine artery occlusion plus partial resection of symptomatic adenomyosis","volume":"176","author":"Liu","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R12-20261107","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.rbmo.2014.02.008","article-title":"Treatment of adenomyomectomy in women with severe uterine adenomyosis using a novel technique","volume":"28","author":"Saremi","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"R13-20261107","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000441783","article-title":"Long-Term efficacy of laparoscopic or robotic adenomyomectomy with or without medical treatment for severely symptomatic adenomyosis","volume":"81","author":"Chong","year":"2016","journal-title":"Gynecol Obstet Invest"},{"key":"R14-20261107","doi-asserted-by":"crossref","first-page":"e2017.00014","DOI":"10.4293\/JSLS.2017.00014","article-title":"Laparoscopic surgery for focal adenomyosis","volume":"21","author":"Kwack","year":"2017","journal-title":"JSLS"},{"key":"R15-20261107","first-page":"3430","article-title":"Recurrence-associated factors of laparoscopic adenomyomectomy for severely symptomatic adenomyoma","volume":"16","author":"Yu","year":"2018","journal-title":"Oncol Lett"},{"key":"R16-20261107","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jog.13658","article-title":"Conservative surgery of uterine adenomyosis via laparoscopic versus laparotomic approach in a single institution","volume":"44","author":"Kwack","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"R17-20261107","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2147\/JPR.S205561","article-title":"Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution","volume":"12","author":"Zhu","year":"2019","journal-title":"J Pain Res"},{"key":"R18-20261107","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/jog.14376","article-title":"The efficacy of medical treatment for adenomyosis after adenomyomectomy","volume":"46","author":"Li","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"R19-20261107","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/a-1337-2690","article-title":"Laparoscopically assisted adenomyomectomy using the double\/multiple-flap method with temporary occlusion of the bilateral uterine artery and utero-ovarian vessels in comparison with the double\/multiple-flap only method","volume":"81","author":"Ji","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R20-20261107","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ijgo.13573","article-title":"Adjuvant therapy in conservative surgery for adenomyosis","volume":"154","author":"Chao","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"R21-20261107","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2214\/ajr.181.3.1810851","article-title":"Adenomyosis: MRI of the uterus treated with uterine artery embolization","volume":"181","author":"Jha","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"R22-20261107","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1148\/radiol.2343031697","article-title":"Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience","volume":"234","author":"Pelage","year":"2005","journal-title":"Radiology"},{"key":"R23-20261107","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2214\/AJR.04.1661","article-title":"MRI of adenomyosis: changes with uterine artery embolization","volume":"186","author":"Kitamura","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"R24-20261107","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2214\/AJR.05.1613","article-title":"Long-term results of uterine artery embolization for symptomatic adenomyosis","volume":"188","author":"Kim","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"R25-20261107","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jvir.2007.10.011","article-title":"Long-term outcome of uterine artery embolization for symptomatic uterine leiomyomas","volume":"19","author":"Lohle","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"R26-20261107","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejrad.2007.12.009","article-title":"Uterine artery embolisation for symptomatic adenomyosis--mid-term results","volume":"70","author":"Bratby","year":"2009","journal-title":"Eur J Radiol"},{"key":"R27-20261107","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jvir.2011.01.426","article-title":"Uterine artery embolization for symptomatic adenomyosis: a new technical development of the 1-2-3 protocol and predictive factors of MR imaging affecting outcomes","volume":"22","author":"Kim","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"R28-20261107","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00270-011-0203-1","article-title":"Long-term follow-up of uterine artery embolization for symptomatic adenomyosis","volume":"35","author":"Smeets","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R29-20261107","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1479-828X.2011.01399.x","article-title":"Efficacy of uterine artery embolisation for treatment of symptomatic fibroids and adenomyosis - an interim report on an Australian experience","volume":"52","author":"Liang","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R30-20261107","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00270-011-0254-3","article-title":"Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata: results of symptom control and health-related quality of life 40 months after treatment","volume":"35","author":"Froeling","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R31-20261107","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00270-014-0878-1","article-title":"Uterine artery embolisation for symptomatic adenomyosis with polyzene F-coated hydrogel microspheres: three-year clinical follow-up using UFS-QoL questionnaire","volume":"38","author":"Nijenhuis","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R32-20261107","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jvir.2015.04.026","article-title":"Uterine artery embolization for adenomyosis: percentage of necrosis predicts midterm clinical recurrence","volume":"26","author":"Bae","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"R33-20261107","doi-asserted-by":"crossref","first-page":"e165610","DOI":"10.1371\/journal.pone.0165610","article-title":"Outcomes in adenomyosis treated with uterine artery embolization are associated with lesion vascularity: a long-term follow-up study of 252 cases","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"key":"R34-20261107","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s00270-017-1686-1","article-title":"Uterine artery embolization for symptomatic adenomyosis: 7-year clinical follow-up using UFS-Qol questionnaire","volume":"40","author":"de Bruijn","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R35-20261107","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/ajo.12767","article-title":"A clinical audit on the efficacy and safety of uterine artery embolisation for symptomatic adenomyosis: results in 117 women","volume":"58","author":"Liang","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R36-20261107","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/ajo.13304","article-title":"Long-term durability of uterine artery embolisation for treatment of symptomatic adenomyosis","volume":"61","author":"Ma","year":"2021","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R37-20261107","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.fertnstert.2010.10.020","article-title":"Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center","volume":"95","author":"Zhou","year":"2011","journal-title":"Fertil Steril"},{"key":"R38-20261107","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ultsonch.2015.05.033","article-title":"Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: a single center experience from the Republic of Korea","volume":"27","author":"Lee","year":"2015","journal-title":"Ultrason Sonochem"},{"key":"R39-20261107","doi-asserted-by":"crossref","first-page":"e2443","DOI":"10.1097\/MD.0000000000002443","article-title":"Clinical predictors of long-term success in ultrasound-guided high-intensity focused ultrasound ablation treatment for adenomyosis: a retrospective study","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R40-20261107","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02656736.2018.1509238","article-title":"High intensity focused ultrasound treatment of adenomyosis: a comparative study","volume":"35","author":"Guo","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"R41-20261107","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1016\/j.ultrasmedbio.2019.08.022","article-title":"Safety and efficacy of ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroids and adenomyosis","volume":"45","author":"Lee","year":"2019","journal-title":"Ultrasound Med Biol"},{"key":"R42-20261107","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/02656736.2019.1679892","article-title":"High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up","volume":"36","author":"Haiyan","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"R43-20261107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/02656736.2021.1886347","article-title":"High-intensity focused ultrasound in the management of adenomyosis: long-term results from a single center","volume":"38","author":"Li","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"R44-20261107","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/02656736.2021.1967467","article-title":"Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results","volume":"38","author":"Peng","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"R45-20261107","first-page":"656","article-title":"Efficacy and safety of magnetic resonance-guided focused ultrasound surgery (MRgFUS) ablation in the management of abnormal uterine bleeding due to uterine leiomyoma or adenomyosis","volume":"14","author":"Huang","year":"2022","journal-title":"Am J Transl Res"},{"key":"R46-20261107","doi-asserted-by":"crossref","first-page":"20160119","DOI":"10.1259\/bjr.20160119","article-title":"Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis","volume":"90","author":"Hai","year":"2017","journal-title":"Br J Radiol"},{"key":"R47-20261107","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jog.14145","article-title":"Pregnancy and symptomatic relief following ultrasound-guided transvaginal radiofrequency ablation in patients with adenomyosis","volume":"46","author":"Nam","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"R48-20261107","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/02656736.2021.1874063","article-title":"Ultrasound-guided transvaginal radiofrequency ablation combined with levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyosis treatment","volume":"38","author":"Hai","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"R49-20261107","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.fertnstert.2011.06.062","article-title":"Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trial","volume":"96","author":"Bouwsma","year":"2011","journal-title":"Fertil Steril"},{"key":"R50-20261107","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajog.2007.09.026","article-title":"Analysis of prognostic factors for patients with leiomyoma treated with uterine arterial embolization","volume":"198","author":"Isonishi","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R51-20261107","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/aogs.13159","article-title":"High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility","volume":"96","author":"Zhang","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R52-20261107","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00270-010-9909-8","article-title":"A comparative study of fibroid ablation rates using radio frequency or high-intensity focused ultrasound","volume":"33","author":"Meng","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R53-20261107","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1479-828X.2008.00855.x","article-title":"Transvaginal radiofrequency thermal ablation: a day-care approach to symptomatic uterine myomas","volume":"48","author":"Cho","year":"2008","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R54-20261107","doi-asserted-by":"crossref","first-page":"hoab030","DOI":"10.1093\/hropen\/hoab030","article-title":"A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis","volume":"2021","author":"Tellum","year":"2021","journal-title":"Hum Reprod Open"},{"key":"R55-20261107","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/humrep\/deac166","article-title":"Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): an international multistakeholder-modified Delphi consensus study","volume":"37","author":"Tellum","year":"2022","journal-title":"Hum Reprod"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:00:39Z","timestamp":1794027639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005080"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005080","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"assertion":[{"value":"2022-09-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}